CLINICAL_TRIALS
trial_result
· 2015-05-12
Clinical Trial Update: Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH) [Phase 3]
Summary
Phase 3 efficacy study of ambrisentan in Chinese patients with pulmonary arterial hypertension has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Vascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-05-12